In vitro anti-viral activity of the total alkaloids from tripterygium hypoglaucum against herpes simplex virus type 1

Virologica Sinica

Volumn 25, Issue 2, 2010, Pages 107-114

  Ren, Zhe ^a,b   Zhang, Chuan Hai ^a,d   Wang, Lian Jun ^a,c   Cui, Yun Xia ^a,c   Qi, Ren Bin ^b   Yang, Chong Ren ^e   Zhang, Ying Jun ^e   Wei, Xiao Yi ^f   Lu, Da Xiang ^b   Wang, Yi Fei ^a,c  

^a JINAN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^c National Engineering Research Center of Genetic Medicine   (China)

^d WEST ANHUI UNIVERSITY   (China)

^e KUNMING INSTITUTE OF BOTANY   (China)

^f SOUTH CHINA INSTITUTE OF BOTANY   (China)

Author keywords

Alkaloid; Antiviral activity; Gene expression; Herpes complex virus; Tripterygium hypoglaucum

Indexed keywords

ACICLOVIR; ALKALOID DERIVATIVE; TRIPTERYGIUM HYPOGLAUCUM EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; ENZYME INHIBITION; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANT ROOT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRIPTERYGIUM; TRIPTERYGIUM HYPOGLAUCUM; VERO CELL; VIRUS GENOME; VIRUS PLAQUE;

ALKALOIDS; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; GENE EXPRESSION; HERPESVIRUS 1, HUMAN; INHIBITORY CONCENTRATION 50; MICROBIAL VIABILITY; PLANT EXTRACTS; PLANT ROOTS; PLAQUE ASSAY; TRANSCRIPTION, GENETIC; TRIPTERYGIUM; VIRAL PROTEINS;

CELASTRACEAE; HERPES; HUMAN HERPESVIRUS 1; TRIPTERYGIUM HYPOGLAUCUM;

EID: 77953333942     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-010-3092-6     Document Type: Article

References (24)

1. Akanitapichat P, Wangmaneerat A, Wilairat P, Bastowc K F. 2006. Anti-herpes virus activity of Dunbaria bella Prain. J Ethnopharmacol, 105: 64-68.
2. Baker J T, Borris R P, Carte B, et al. 1995. Natural product drug discovery and development: new perspectives on international collaboration. J Nat Prod, 58: 1325-1357.
3. Boehmer P E, Lehman, I R. 1997. Herpes simplex virus DNA replication. Annu. Rev. Biochem. 66, 347-384.
4. Brinker A M, Ma J, Lipsky P E, et al. 2007. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry, 68: 732-766.
5. Cheng H Y, Lin, C C, Lin T C. 2002. Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn. Antiviral Res, 55:447-455.
6. Chang L C, Chang W, Chang M Y, et al. 2002. Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res, 55: 53-62.
7. Coen D M. 1996. Antiviral drug resistance in herpes simplex virus. Adv Exp Med Biol, 394: 49-57.
8. Duan H Q, Takaishi Y, Imakura Y, et al. 2000. Sesquiterpene alkaloids from Tripterygium hypoglaucum and Tripterygium wilfordii: a new class of potent anti-HIV agents. J Nat Prod, 63: 357-361.
9. Fritz D, Venturi C R, Cargnin S, et al. 2007. Herpes virus inhibitory substances from Hypericum connatum Lam., a plant used in southern Brazil to treat oral lesions. J Ethnopharmacol, 113: 517-520.
10. Fujita R, Duan H, Takaishi Y. 2000. Terpenoids from Tripterigyum hypoglaucum. Phytochemisty, 53(6): 715-722.
11. Kimberlin D W, Whitley R J. 1996. Antiviral resistance: mechanisms, clinical significance, and future implications. J Antimicrob Chemoth, 37: 403-421.
12. Kleymann G. 2003. Novel agents and strategies to treat herpes simplex infections. Expert Opin Invest Drugs, 12: 165-183.
13. Mosmann T. 1983. Rapid colorimetric assay for cellular growth survival: Application to proliferation and cytoxicity assays. J Immunol Methods, 65: 55-63.
14. Patwardhan B, Gautam, M. 2005. Botanical immunodrugs: scope and opportunities. Drug Discov Today, 10:495-502.
15. Reed L J, Muench H. 1938. A simple method for estimating fifty percent end points. Am J Hygiene, 27: 493-497.
16. Roizman B. 1999. HSV gene function: what have we learned that could be generally applicable to its near and distant cousins? Acta virol, 43, 75-80.
17. Roizman B, Sears A E. 1990. Herpes simples virus and their replication. In: Virology (Fields B N, Knipe D M, Howley P M, et al. eds.), 2nd ed. New York: Raven Press, p 1795-1841.
18. Smith J S, Robinson N J. 2002. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis, 186 (Suppl. 1):S3-S28.
19. Subak-Sharpe J H, Dargan D J. 1998. HSV molecular biology: general aspects of herpes simplex virus molecular biology. Virus Genes, 16: 239-251.
20. Tao J, Hu Q X, Yang J, Li R R, et al. 2007. In vitro anti-HIV and-HSV activity and safety of sodium rutin sulfate as a microbicide candidate. Antiviral Res, 75: 227-233.
21. Vlietinck A J, Vanden Berghe D A. 1991. Can ethnopharmacology contribute to the development of antiviral drugs? J Ethnopharmacol, 32, 141-153.
22. Wang R R, Gu Q, Yang L M, et al. 2006. Anti-HIV-1 activities of extracts from the medicinal plant Rhus chinensis. J Ethnopharmacol, 105:269-273.
23. Whtley R J, Kimberlin D W, Roizman B. 1998. Herpes simplex viruses. Clin Infect Dis, 26:541-553.
24. Zhang C H, Wang Y F, Liu X J, et al. 2005. Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro. Chin Med J, 118: 493-496.